WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone. Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic. Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid. The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity. |
Jordan stations 2 firefighting helicopters in Cyprus to help as summer fire season arrivesLos Angeles hotel famous for Pretty Woman goes Back To The FutureTurkey says it has carried out new airstrikes against Kurdish militants in northern IraqUS and Philippine forces stage combat drills near strategic channel off southern TaiwanCall it Cognac diplomacy. France offered China’s Xi a special drink, in a wink at their trade spatGeorgia's attorney general says Savannah overstepped in outlawing guns in unlocked carsGeorgia's attorney general says Savannah overstepped in outlawing guns in unlocked carsStars and DeBoer moving on after ousting Cup champ Vegas in tight 7Trump's strategist push AI to help conservatives, all you need to knowHow Rita Moreno uses honors like an upcoming public television award to further her philanthropy